Literature DB >> 1650043

Foscarnet therapy of ganciclovir-resistant cytomegalovirus in marrow transplantation.

W R Drobyski1, K K Knox, D R Carrigan, R C Ash.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1650043

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  13 in total

Review 1.  Prevention of viral infections after bone marrow transplantation.

Authors:  U Schuler; G Ehninger
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 2.  Viral skin infections: diagnosis and treatment considerations.

Authors:  Kyoung C Park; Won S Han
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.

Authors:  F Baldanti; M R Underwood; S C Stanat; K K Biron; S Chou; A Sarasini; E Silini; G Gerna
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Novel mutation in the UL97 gene of a clinical cytomegalovirus strain conferring resistance to ganciclovir.

Authors:  M N Hanson; L C Preheim; S Chou; C L Talarico; K K Biron; A Erice
Journal:  Antimicrob Agents Chemother       Date:  1995-05       Impact factor: 5.191

Review 5.  Antimicrobial strategies in the care of organ transplant recipients.

Authors:  R H Rubin; N E Tolkoff-Rubin
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 6.  "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.

Authors:  A K Field; K K Biron
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

Review 7.  Resistance of human cytomegalovirus to antiviral drugs.

Authors:  A Erice
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

8.  How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.

Authors:  Firas El Chaer; Dimpy P Shah; Roy F Chemaly
Journal:  Blood       Date:  2016-10-19       Impact factor: 22.113

9.  The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.

Authors:  J Neyts; G Andrei; R Snoeck; G Jähne; I Winkler; M Helsberg; J Balzarini; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

10.  Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients.

Authors:  M A Slavin; R R Bindra; C A Gleaves; M B Pettinger; R A Bowden
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.